Hypofractionated stereotactic re-irradiation: Treatment option in recurrent malignant glioma

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Vordermark, Dirk ^a   Kölbl, Oliver ^a   Ruprecht, Klemens ^a   Vince, Giles H ^a   Bratengeier, Klaus ^a   Flentje, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; NIMUSTINE; PREDNISONE; TEMOZOLOMIDE; TENIPOSIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HEALTH CARE FACILITY; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; REOPERATION; SALVAGE THERAPY; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT PLANNING; TUMOR GROWTH; TUMOR RECURRENCE; BRAIN TUMOR; DISEASE COURSE; GLIOMA; METHODOLOGY; PATHOLOGY; RADIATION RESPONSE; RADIOSURGERY; RADIOTHERAPY; RECURRENT DISEASE; STEREOTACTIC PROCEDURE; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DISEASE PROGRESSION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GLIOBLASTOMA; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; NIMUSTINE; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY; RECURRENCE; STEREOTAXIC TECHNIQUES; TENIPOSIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 26844436461     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-55     Document Type: Article

References (14)

1. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M: 3-D recurrence patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 1999, 53:53-57.
2. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB: Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 1999, 45:1133-1141.
3. van Kampen M, Engenhart-Cabilic R, Debus J, Fuß M, Rhein B, Wannenmacher M: The value of radiosurgery for recurrent glioblastoma multiforme (German). The Heidelberg experience and review of the literature. Strahlenther Onkol 1998, 174:19-24.
4. Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M: Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997, 37:393-398.
5. Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ: A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 1999, 43:291-298.
6. Glass J, Silverman CL, Axelrod R, Corn BW, Andrews DW: Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive or persistent malignant astrocytoma. Am J Clin Oncol 1997, 20:226-229.
7. Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E, Wrzolek M: Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 2000, 23:155-159.
8. Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R, Dowsett R: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 2002, 25:606-611.
9. Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society: Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 2003, 21:3276-3284.
10. Willner J, Flentje M, Bratengeier K: CT-simulation in stereotactic brain radiotherapy - analysis of isocenter reproducibility with mask fixation. Radiother Oncol 1997, 45:83-88.
11. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345:1008-1012.
12. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke, Allgäuer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A: Salvage Therapy in patients with glioblastoma. Is there any benefit? Cancer 2003, 98:2678-86.
13. Nieder C, Grosu AL, Molls M: A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 2000, 26:397-409.
14. Dhermain F, de Crevoisier R, Parker F, Cioloca C, Kaliski A, Beaudre A, Lefkopoulos D, Armand JP, Haie-Meder C: Role of radiotherapy in recurrent gliomas [French]. Bull Cancer 2004, 91:883-889.